Browsing: Lymphoma

A common question is how best to balance response and toxicity when palliating the unique radiobiology of multiple myeloma. This…

The editorial accompanying the Euronet-PHL-C1 trial puts into writing the question that’s been on the minds of rad oncs for…

Top Line: Can radiation be omitted based on response to systemic therapy for children with early stage Hodgkin lymphoma?The Study:…

  December 15, 2022 N it to win it. Top Line: Immune checkpoint inhibitors are used for relapsed and refractory…

Top Line: Is PET-adaptive therapy a safe option for patients with bulky early stage Hodgkin lymphoma? The Study: There have…

This prospective phase 2 trial demonstrates that 45 of 50 patients receiving only 2 Gy x 2 for indolent B-cell…

This NCDB analysis of 3201 patients with stage I nodal marginal zone lymphoma suggests, of the three NCCN-sanctioned treatment algorithms…